Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
0(0%)
Results Posted
38%(3 trials)

Phase Distribution

Ph phase_3
1
13%
Ph early_phase_1
1
13%
Ph phase_2
2
25%
Ph phase_4
2
25%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(8)

Detailed Status

Completed8

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 42 (33.3%)

Trials by Status

completed8100%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_2

Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury

NCT02962102
completed

Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).

NCT06279910
completedphase_3

Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)

NCT02548364
completed

Calcifediol in the Treatment of COVID 19

NCT05819918
completedearly_phase_1

25-Hydroxyvitamin D Pharmacokinetic Study

NCT03401541
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02962102Phase 2

Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury

Completed
NCT06279910

Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).

Completed
NCT02548364Phase 3

Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)

Completed
NCT05819918

Calcifediol in the Treatment of COVID 19

Completed
NCT03401541Early Phase 1

25-Hydroxyvitamin D Pharmacokinetic Study

Completed
NCT02527668Phase 2

To Test the Effect of Calcifediol Hy.D Supplementation on Muscle Function and Bone Quality in Younger Postmenopausal Women With Osteopenia

Completed
NCT01939977Phase 4

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.

Completed
NCT02805907Phase 4

Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)

Completed

All 8 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
8